Initial Management of Hypovolemic Shock
Begin immediate fluid resuscitation with isotonic crystalloids, administering at least 30 mL/kg IV within the first 3 hours, while simultaneously identifying and controlling the source of volume loss. 1
Immediate Priorities
Fluid Resuscitation Strategy
Crystalloids are the first-line fluid of choice for initial resuscitation in hypovolemic shock 2, 1. The evidence strongly supports isotonic crystalloid solutions over colloids, with multiple guidelines converging on this recommendation.
- Initial bolus: Administer 30 mL/kg of IV crystalloid fluid within the first 3 hours 1
- Bolus technique: In trauma settings, give 20 mL/kg boluses over 5-10 minutes, reassessing after each bolus 2
- Pediatric approach: Use 10-20 mL/kg aliquots with frequent reassessment 3
Either balanced crystalloids (lactated Ringer's) or normal saline can be used, though some evidence suggests balanced solutions may reduce complications 1. However, avoid hypotonic solutions like Ringer's lactate in patients with severe head trauma 4.
Permissive Hypotension in Hemorrhagic Shock
In trauma patients with uncontrolled hemorrhage, target a mean arterial pressure (MAP) of 65 mmHg rather than normal blood pressure until bleeding is controlled 2. This "permissive hypotension" strategy prevents exacerbation of bleeding from aggressive fluid resuscitation.
Critical exceptions where permissive hypotension is contraindicated:
- Traumatic brain injury (requires adequate cerebral perfusion pressure)
- Spinal cord injuries
- Elderly patients
- Patients with chronic hypertension 2
Continuous Reassessment
After every fluid bolus, reassess hemodynamic status using multiple parameters 1:
- Heart rate and blood pressure
- Capillary refill time (<2 seconds is normal)
- Urine output (target >0.5 mL/kg/hr)
- Mental status
- Skin temperature and mottling
- Lactate levels (target normalization)
Use dynamic variables over static variables to predict fluid responsiveness when available 1. This prevents fluid overload, which increases morbidity including mechanical ventilation requirements and worsening oxygenation 3.
Source Control
Identify and control the source of volume loss as rapidly as possible 1. This is equally important as fluid resuscitation:
- Hemorrhage control: Surgical intervention, endoscopic therapy, or interventional radiology as indicated
- Pelvic fractures: Immediate pelvic ring closure and stabilization in hemorrhagic shock 4
- Damage control surgery: Employ in severely injured patients with deep hemorrhagic shock, ongoing bleeding, and coagulopathy 4
Vasopressor Support
If hypotension persists despite adequate fluid resuscitation (fluid-refractory shock), initiate vasopressor therapy targeting MAP ≥65 mmHg 1.
- First-line agent: Norepinephrine 1
- Alternative: Epinephrine (can be added to or substituted for norepinephrine) 1
- Pediatric considerations: Either epinephrine or norepinephrine are reasonable initial choices; dopamine may be considered if these are unavailable 3
Important caveat: Early vasopressor use should not substitute for adequate fluid resuscitation. One study suggests premature vasopressor use may be deleterious 2. Vasopressors are indicated only after appropriate fluid loading or when fluid administration would cause harm (e.g., pulmonary edema).
Monitoring and Adjuncts
Serial lactate measurements guide resuscitation adequacy. Lactate clearance and normalization correlate with improved outcomes 5. Even small elevations above 2.0 mmol/L are associated with increased mortality.
Avoid albumin and hydroxyethyl starches as first-line therapy. Multiple meta-analyses show either no benefit or potential harm with colloids compared to crystalloids 2, 1, 6. Albumin may be considered only when patients require substantial amounts of crystalloids 1.
Common Pitfalls
Excessive crystalloid administration: Large volumes (>3-4 L) increase coagulopathy risk and abdominal compartment syndrome 2. Reassess frequently and transition to blood products in hemorrhagic shock.
Ignoring ongoing losses: Fluid resuscitation must match ongoing losses. Failure to control bleeding source leads to futile resuscitation.
Inadequate monitoring: Single measurements are insufficient. Serial assessments of perfusion markers (lactate, urine output, mental status, skin perfusion) are essential 5.
Delayed hemorrhage control: Fluid resuscitation buys time but is not definitive treatment. Surgical or interventional control should not be delayed 1, 4.